Mayo Clinic Laboratory and pathology research roundup: September 14
Share this:
The research roundup provides an overview of the past week’s research from Mayo Clinic Laboratories consultants, including featured abstracts and a complete list of published studies and reviews.
Featured Abstract
Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19.
Thrombosis and inflammation may contribute to the risk of death and complications among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation may improve outcomes in noncritically ill patients who are hospitalized with Covid-19. Via PubMed
Published to PubMed This Week
- Integrated exome and RNA sequencing of TFE3-translocation renal cell carcinoma.
Nature Communications - Clinical heterogeneity of the VEXAS syndrome: A case series.
Mayo Clinic Proceedings - Metaplastic breast cancer.
Mayo Clinic Proceedings - Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma.
International Journal of Cancer - Isotopic distribution calibration for mass spectrometry.
Analytical Chemistry - Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast.
NPJ Breast Cancer - Multiparametric magnetic resonance imaging/magnetic resonance elastography assesses progression and regression of steatosis, inflammation, and fibrosis in alcohol-associated liver disease.
Alcoholism, Clinical and Experimental Research - Mesenchymal stem/stromal cells and their extracellular vesicle progeny decrease injury in poststenotic swine kidney through different mechanisms.
Stems, Cells and Development - mRNA vaccine effectiveness against asymptomatic SARS-CoV-2 infection over a seven-month period.
Infection Control and Hospital Epidemiology - Crimean-Congo hemorrhagic fever-induced liver injury: a systematic review and meta-analysis.
International Journal of Clinical Practice
